We recently raised a $126M Series C at a $3.5B valuation, led by Avenir Growth, bringing total funding to $404M with participation from CapitalG, General Catalyst, a16z, Kleiner Perkins, Premji Invest, UHS, Cincinnati Children's, WellSpan Health, John Doerr, Rick Klausner, and others. This isn't a dashboarding role - you'll help define what "good" looks like for AI clinical agents (including critic frameworks and quality criteria), not just track adoption of a finished product.